AHA Names Top CVD Advances for 2023
Advances in stroke, a novel antihypertensive, and new evidence that diabetes drugs may offer CVD benefits for those without diabetes are among the top developments in 2023, on the AHA's annual list.
United States Mariell Jessup George Bakris Chiadi Ndumele Johns Hopkins University In Baltimore Nurse Health Study
Source: medscape.com